Clinical Trial Update: Study of an Evening Dose of Eszopiclone on Next Day Driving Ability & Psychomotor/Memory Function in Healthy Volunteers [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating an evening dose of eszopiclone on next-day driving ability and psychomotor/memory function in healthy volunteers; the study has been co…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Insomnia

Drugs mentioned

• Lunesta (eszopiclone)

Snippet

Sponsor: Sumitomo Pharma America, Inc. | Conditions: Insomnia | Phase 1 | Status: COMPLETED